Business

Medacta : Extends MyImplant Platform to Complex Hip Reconstruction

Medacta : Extends MyImplant Platform to Complex Hip

articleMedacta Group SaApril 2, 20265/news/medacta-extends-myimplant-platform-to-complex-hip-reconstruction
Medacta : Extends MyImplant Platform to Complex Hip Reconstruction

About this update from Medacta Group Sa

April 2, 2026 Medacta Extends MyImplant Platform to Complex Hip Reconstruction CASTEL SAN PIETRO, April 2, 2026 - Medacta Group SA ("Medacta" SIX: MOVE) today announces the expansion of its MyImplant platform from established shoulder applications to hip reconstruction, providing an innovative custom-fit solution developed to support surgeons in managing complex cases, particularly in situations where fixation may be challenging due to extensive bone loss. MyImplant is built on Medacta's strong and long-standing expertise in 3D planning, additive manufacturing, and patient-matched solutions - a foundation developed over more than fifteen years through continuous innovation and real-world clinical application. Central to this ecosystem is Medacta's advanced 3D Metal technology and the MySolutions Personalized Ecosystem, which together enable precise anatomical restoration and optimized biomechanics. This depth of experience translates into implants designed to support long-term stability and, ultimately, to improve patient quality of life. The new MyImplant solution for hip procedures was unveiled during the recent M.O.R.E. International Hip Symposium in Paris (March 12-13), an event that also celebrated more than 20 years of the Versafitcup and Quadra systems, supported by the AMIS surgical technique and HIGHCROSS polyethylene. This milestone reflects Medacta's long-standing commitment to advancing MIS Hip Replacement through continuous innovation in implants, minimally invasive techniques, advanced materials, and tailored education. It is this depth of experience, backed by strong clinical evidence and long-term outcomes, that underpins the development of MyImplant for complex acetabular reconstruction. While MyImplant applications in shoulder surgery primarily focus on glenoid reconstruction, the new hip solution is intended to address complex acetabular reconstruction, further expanding the Medacta Hip Revision Platform and strengthening the company's ability to support surgeons in managing high-complexity cases. "In my experience, the advanced level of customization of MyImplant contributes to simplifying the management of complex acetabular defects in a relevant and effective manner", said Dr. med. Alois Franz, Marien Kliniken Siegen, Germany. Advanced software, combined with patient CT scans, enables precise preoperative planning and surgical simula...

View stock analysis, news, and events for Medacta Group Sa